Conclusions
LAVI ≥ 30 mL/m2 may provide a simple, intuitive, and
clinical meaningful risk stratification for development of AF after CTI
AFL ablation. The utility of elevated LAVI in patients undergoing
typical AFL ablation to identify patients most likely to benefit from
prophylactic PVI or more intensive monitoring prior to discontinuation
of anticoagulation requires further evaluation.
Sources of Funding: None
Disclosures: Dr. Barbhaiya has received speaking fees/honoraria
from Abbott, Inc., and Medtronic, Inc. Dr. Aizer has received fellowship
support from Abbott, Inc., Biotronik, Inc., Boston Scientific, Inc., and
Medtronic, Inc, and Biosense Webster, Inc. Dr. Chinitz has received
speaking fees / honoraria from Abbott, Medtronic, Biotronik, Biosense
Webster